BREAKTHROUGHS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the sphere of biopharmaceuticals, providing promising progress throughout several health care and industrial programs. With its structural similarity to Normally derived human serum albumin, OsrHSA delivers a safer, much more trustworthy option for therapeutic use,